GWN Securities Inc. Invests $232,000 in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

GWN Securities Inc. bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,970 shares of the company’s stock, valued at approximately $232,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. D1 Capital Partners L.P. acquired a new stake in GE HealthCare Technologies during the 3rd quarter valued at $268,159,000. Van ECK Associates Corp increased its holdings in GE HealthCare Technologies by 107.3% during the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock valued at $378,520,000 after purchasing an additional 2,506,417 shares in the last quarter. State Street Corp increased its holdings in GE HealthCare Technologies by 7.8% during the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company’s stock valued at $1,747,101,000 after purchasing an additional 1,347,114 shares in the last quarter. Massachusetts Financial Services Co. MA acquired a new stake in GE HealthCare Technologies during the 3rd quarter valued at $93,713,000. Finally, Jennison Associates LLC increased its holdings in GE HealthCare Technologies by 124.5% during the 4th quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock valued at $133,659,000 after purchasing an additional 948,017 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Up 0.6 %

NASDAQ:GEHC opened at $82.47 on Tuesday. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $37.71 billion, a P/E ratio of 19.05, a P/E/G ratio of 3.19 and a beta of 1.13. The stock’s fifty day simple moving average is $87.27 and its 200-day simple moving average is $86.12.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on GEHC. Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their price objective for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.